These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19553638)

  • 1. Improving survival in patients with chronic lymphocytic leukemia (1980-2008): the Hospital Clinic of Barcelona experience.
    Abrisqueta P; Pereira A; Rozman C; Aymerich M; Giné E; Moreno C; Muntañola A; Rozman M; Villamor N; Hodgson K; Campo E; Bosch F; Montserrat E
    Blood; 2009 Sep; 114(10):2044-50. PubMed ID: 19553638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden.
    Kristinsson SY; Dickman PW; Wilson WH; Caporaso N; Björkholm M; Landgren O
    Haematologica; 2009 Sep; 94(9):1259-65. PubMed ID: 19734417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is changing in the natural history of chronic lymphocytic leukemia?
    Molica S; Levato D
    Haematologica; 2001 Jan; 86(1):8-12. PubMed ID: 11146563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.
    Wu SJ; Chiang CJ; Lin CT; Tien HF; Lai MS
    PLoS One; 2013; 8(4):e62930. PubMed ID: 23638168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases.
    Molica S; Brugiatelli M; Callea V; Morabito F; Levato D; Nobile F; Alberti A
    Eur J Haematol; 1994 Apr; 52(4):216-21. PubMed ID: 8005231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic lymphocytic leukemia in Iceland from 2003 to 2013: Incidence, presentation and diagnosis].
    Olafsson GB; Steingrimsdottir H; Vidarsson B; Halldorsdottir AM
    Laeknabladid; 2016 Apr; 102(4):171-7. PubMed ID: 27197124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of early chronic lymphocytic leukemia. A single institution study with emphasis on the impact of disease-progression on overall survival.
    Molica S; Levato D; Dattilo A
    Haematologica; 1999 Dec; 84(12):1094-9. PubMed ID: 10586211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States.
    Shenoy PJ; Malik N; Sinha R; Nooka A; Nastoupil LJ; Smith M; Flowers CR
    Clin Lymphoma Myeloma Leuk; 2011 Dec; 11(6):498-506. PubMed ID: 21889433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival and Clinical Aspects for Patients with Chronic Lymphocytic Leukemia in Kermanshah, Iran.
    Payandeh M; Sadeghi E; Sadeghi M
    Asian Pac J Cancer Prev; 2015; 16(17):7987-90. PubMed ID: 26625830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The American College of Surgeons Commission on Cancer and the American Cancer Society. The National Cancer Data Base report on age, gender, treatment, and outcomes of patients with chronic lymphocytic leukemia.
    Diehl LF; Karnell LH; Menck HR
    Cancer; 1999 Dec; 86(12):2684-92. PubMed ID: 10594864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous stem cell transplantation as a first-line treatment strategy for chronic lymphocytic leukemia: a multicenter, randomized, controlled trial from the SFGM-TC and GFLLC.
    Sutton L; Chevret S; Tournilhac O; Diviné M; Leblond V; Corront B; Leprêtre S; Eghbali H; Van Den Neste E; Michallet M; Maloisel F; Bouabdallah K; Decaudin D; Berthou C; Brice P; Gonzalez H; Chapiro E; Radford-Weiss I; Leporrier N; Maloum K; Nguyen-Khac F; Davi F; Lejeune J; Merle-Béral H; Leporrier M;
    Blood; 2011 Jun; 117(23):6109-19. PubMed ID: 21406717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common polymorphism G(-248)A in the promoter region of the bax gene results in significantly shorter survival in patients with chronic lymphocytic Leukemia once treatment is initiated.
    Starczynski J; Pepper C; Pratt G; Hooper L; Thomas A; Milligan D; Bentley P; Fegan C
    J Clin Oncol; 2005 Mar; 23(7):1514-21. PubMed ID: 15735127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National trends in incidence and survival of chronic lymphocytic leukemia in Norway for 1953-2012: a systematic analysis of population-based data.
    Lenartova A; Johannesen TB; Tjønnfjord GE
    Cancer Med; 2016 Dec; 5(12):3588-3595. PubMed ID: 27925456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative assessment of prognostic models in chronic lymphocytic leukemia: evaluation in Indian cohort.
    Rani L; Gogia A; Singh V; Kumar L; Sharma A; Kaur G; Gupta R
    Ann Hematol; 2019 Feb; 98(2):437-443. PubMed ID: 30338367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
    Delgado J; Doubek M; Baumann T; Kotaskova J; Molica S; Mozas P; Rivas-Delgado A; Morabito F; Pospisilova S; Montserrat E
    Am J Hematol; 2017 Apr; 92(4):375-380. PubMed ID: 28120419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.
    International CLL-IPI working group
    Lancet Oncol; 2016 Jun; 17(6):779-790. PubMed ID: 27185642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the impact of age and disease on survival of chronic lymphocytic leukaemia patients by a new method.
    Klepfish A; Rachmilewitz EA; Sarid M; Schattner A
    Int J Clin Pract; 2009 Nov; 63(11):1601-3. PubMed ID: 19832816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul.
    Pamuk ON; Pamuk GE; Soysal T; Ongören S; Başlar Z; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
    South Med J; 2004 Mar; 97(3):240-5. PubMed ID: 15043330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.